Clinical Trial Update: A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches [Phase 2]

View source ↗

Summary

Phase 2 multicenter trial evaluating the efficacy of a 91-day extended-cycle oral contraceptive for menstrually-related migraine headaches; results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• 91-day extended cycle oral contraceptive

Snippet

Sponsor: Duramed Research | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2014-08-29